Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

aehr test systems - AEHR

AEHR

Close Chg Chg %
95.51 0.40 0.42%

Closed Market

95.91

+0.40 (0.42%)

Volume: 2.66M

Last Updated:

Apr 24, 2026, 4:00 PM EDT

Trade Now

Company Overview: aehr test systems - AEHR

AEHR Key Data

Open

$98.78

 Day Range

94.53 - 102.48

52 Week Range

8.02 - 102.48

 Market Cap

$2.95B

Shares Outstanding

31.45M

 Public Float

29.60M

Beta

2.29

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.38

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

4.15M

  

AEHR Performance

1 Week
 
 14.37%
 
1 Month
 
 194.93%
 
3 Months
 
 242.05%
 
1 Year
 
 994.86%
 
5 Years
 
 4,016.31%
 

AEHR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About aehr test systems - AEHR

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

AEHR At a Glance

Aehr Test Systems
400 Kato Terrace
Fremont, California 94539
Phone 1-510-623-9400 Revenue 58.97M
Industry Electronic Production Equipment Net Income -3,910,000.00
Sector Electronic Technology Employees 136
Fiscal Year-end 05 / 2026
View SEC Filings

AEHR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 4.786
Price to Book Ratio 2.32
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -289.518
Enterprise Value to Sales 4.542
Total Debt to Enterprise Value 0.04

AEHR Efficiency

Revenue/Employee 433,588.235
Income Per Employee -28,750.00
Receivables Turnover 3.314
Total Asset Turnover 0.427

AEHR Liquidity

Current Ratio 5.677
Quick Ratio 2.991
Cash Ratio 1.613

AEHR Profitability

Gross Margin 40.586
Operating Margin -7.314
Pretax Margin -7.277
Net Margin -6.631
Return on Assets -2.829
Return on Equity -3.335
Return on Total Capital -2.924
Return on Invested Capital -3.127

AEHR Capital Structure

Total Debt to Total Equity 8.814
Total Debt to Total Capital 8.10
Total Debt to Total Assets 7.293
Long-Term Debt to Equity 8.074
Long-Term Debt to Total Capital 7.42
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aehr Test Systems - AEHR

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
50.83M 64.96M 66.22M 58.97M
Sales Growth
+206.20% +27.80% +1.94% -10.95%
Cost of Goods Sold (COGS) incl D&A
27.16M 32.22M 33.67M 35.03M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
307.00K 450.00K 1.36M 3.39M
Depreciation
307.00K 450.00K 1.36M 2.19M
Amortization of Intangibles
- - - 1.20M
-
COGS Growth
+157.04% +18.59% +4.53% +4.04%
Gross Income
23.66M 32.75M 32.54M 23.93M
Gross Income Growth
+292.32% +38.37% -0.62% -26.46%
Gross Profit Margin
+46.56% +50.41% +49.15% +40.59%
2022 2023 2024 2025 5-year trend
SG&A Expense
15.87M 19.37M 22.46M 28.25M
Research & Development
5.82M 7.13M 8.72M 10.46M
Other SG&A
10.05M 12.24M 13.75M 17.78M
SGA Growth
+55.33% +22.10% +15.97% +25.73%
Other Operating Expense
- - - -
-
Unusual Expense
- - (1.70M) 1.36M
-
EBIT after Unusual Expense
9.50M 13.38M 10.08M (5.68M)
Non Operating Income/Expense
43.00K 1.24M 2.38M 1.39M
Non-Operating Interest Income
13.00K 1.25M 2.39M 1.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
9.54M 14.62M 12.46M (4.29M)
Pretax Income Growth
+532.89% +53.20% -14.77% -134.44%
Pretax Margin
+18.77% +22.50% +18.81% -7.28%
Income Tax
91.00K 60.00K (20.70M) (381.00K)
Income Tax - Current - Domestic
91.00K 28.00K 20.00K 7.00K
Income Tax - Current - Foreign
- 32.00K 55.00K 33.00K
Income Tax - Deferred - Domestic
- - (20.77M) (421.00K)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
9.45M 14.56M 33.16M (3.91M)
Minority Interest Expense
- - - -
-
Net Income
9.45M 14.56M 33.16M (3.91M)
Net Income Growth
+566.21% +54.04% +127.77% -111.79%
Net Margin Growth
+18.59% +22.41% +50.07% -6.63%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
9.45M 14.56M 33.16M (3.91M)
Preferred Dividends
- - - -
-
Net Income Available to Common
9.45M 14.56M 33.16M (3.91M)
EPS (Basic)
0.3633 0.5239 1.1505 -0.1322
EPS (Basic) Growth
+520.49% +44.21% +119.60% -111.49%
Basic Shares Outstanding
26.01M 27.79M 28.82M 29.58M
EPS (Diluted)
0.3402 0.4983 1.1195 -0.1322
EPS (Diluted) Growth
+493.75% +46.47% +124.66% -111.81%
Diluted Shares Outstanding
27.77M 29.21M 29.62M 29.58M
EBITDA
8.11M 13.82M 11.44M (925.00K)
EBITDA Growth
+309.38% +70.53% -17.24% -108.08%
EBITDA Margin
+15.95% +21.28% +17.28% -1.57%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 61.667
Number of Ratings 5 Current Quarters Estimate -0.008
FY Report Date 05 / 2026 Current Year's Estimate -0.095
Last Quarter’s Earnings -0.05 Median PE on CY Estimate N/A
Year Ago Earnings 0.15 Next Fiscal Year Estimate 0.15
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 3 4 4
Mean Estimate -0.01 -0.01 -0.10 0.15
High Estimates 0.00 0.02 -0.08 0.20
Low Estimate -0.02 -0.05 -0.11 0.10
Coefficient of Variance -127.65 -263.40 -13.59 27.76

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 2 1
OVERWEIGHT 0 0 0
HOLD 2 2 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Hold

Insider Actions for Aehr Test Systems - AEHR

Date Name Shares Transaction Value
Apr 21, 2026 Vernon Rogers Exec VP of Sales & Mktg. 159,202 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $90 per share 14,328,180.00
Apr 21, 2026 Rhea J. Posedel Director; Director 396,979 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $88.09 per share 34,969,880.11
Apr 21, 2026 Alistair N Sporck VP Contactor Business Unit 20,294 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $83.86 per share 1,701,854.84
Apr 16, 2026 Geoffrey G. Scott Director 100,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.79 per share 6,779,000.00
Apr 16, 2026 Geoffrey G. Scott Director 110,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $68.12 per share 7,493,200.00
Apr 16, 2026 Geoffrey G. Scott Director 135,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $68 per share 9,180,000.00
Apr 16, 2026 Didier Wimmers Executive VP of R&D 12,559 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $71.11 per share 893,070.49
Apr 16, 2026 Didier Wimmers Executive VP of R&D 10,659 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.02 per share 767,661.18
Apr 16, 2026 Donald P. Richmond CTO 181,512 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $73.18 per share 13,283,048.16
Apr 15, 2026 Adil Engineer Chief Operating Officer 41,055 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 2,891,503.65
Apr 15, 2026 Vernon Rogers Exec VP of Sales & Mktg. 166,633 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74.38 per share 12,394,162.54
Apr 15, 2026 Adil Engineer Chief Operating Officer 42,641 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $66.32 per share 2,827,951.12
Apr 15, 2026 Donald P. Richmond CTO 198,523 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74.38 per share 14,766,140.74
Apr 15, 2026 Alistair N Sporck VP Contactor Business Unit 22,635 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 1,594,183.05
Apr 15, 2026 Christopher P. Siu CFO 70,740 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 4,982,218.20
Apr 15, 2026 Adil Engineer Chief Operating Officer 41,441 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $66.27 per share 2,746,295.07
Apr 15, 2026 Gayn Erickson President and CEO; Director 197,723 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $70.58 per share 13,955,289.34
Apr 15, 2026 Gayn Erickson President and CEO; Director 188,295 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 13,261,616.85
Apr 15, 2026 Gayn Erickson President and CEO; Director 191,999 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $70.58 per share 13,551,289.42
Jan 27, 2026 Laura Oliphant Director; Director 18,672 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.45 per share 587,234.40

Aehr Test Systems in the News